Sensorion SA

EPA:ALSEN.PA

0.68 (EUR) • At close November 14, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) EUR.

2024 Q22023 Q42023 Q22022 Q42022 Q22021 Q42021 Q22020 Q42020 Q22019 Q42019 Q22018 Q42018 Q22017 Q42017 Q22016 Q42016 Q22015 Q42015 Q22014 Q42014 Q32014 Q22014 Q12013 Q42013 Q32013 Q22013 Q12012 Q42012 Q32012 Q22012 Q12011 Q4
Revenue 3.1353.0112.5543.0421.8922.7121.5521.480.8731.4141.0420.9721.2590.8871.047-1.0651.082-0.2920.450.00800.2240000000000
Cost of Revenue 0.5690.4790.4760.3930.3770.3510.1620.2180.1970.0950.21600006.77603.69600.924000000000000
Gross Profit 2.5662.5322.0782.6491.5142.3611.3891.2610.6761.320.8270.9721.2590.8871.047-7.8411.082-3.9880.45-0.91600.2240000000000
Gross Profit Ratio 0.8190.8410.8130.8710.80.870.8950.8520.7740.9330.79311117.365113.6381-109.312010000000000
Reseach & Development Expenses 14.6610.48511.85811.51210.7628.3175.8493.8753.5174.9825.2276.0585.853.9313.9411.4874.1682.0021.5481.3490.5670.9190.5670.5670.3070.3070.3070.3070.1780.1780.1780.178
General & Administrative Expenses 0000000001.2191.2191.0191.5042.141.5281.2181.2180.4130.4130.4870.2220.3840.2220.2220.1680.1680.1680.1680.1270.1270.1270.127
Selling & Marketing Expenses 0000000000.547-0.1860.1590.130.130.043-0.6340.1130.6610.0980.13100.0720000000000
SG&A 3.9222.8422.4962.1042.9562.9371.7351.631.8541.7661.0331.1781.6342.2711.5710.5831.3311.0730.510.6170.2220.4560.2220.2220.1680.1680.1680.1680.1270.1270.1270.127
Other Expenses -15.566-0.202000000000000000000-1.559-1.559-1.559-1.559-0.886-0.886-0.886-0.886-0.551-0.551-0.551-0.551
Operating Expenses 3.01613.12514.35413.61613.71811.2547.5835.5045.3716.7486.267.1047.3525.9835.4673.0025.3770.141.941.8-0.771.297-0.77-0.77-0.412-0.412-0.412-0.412-0.247-0.247-0.247-0.247
Operating Income 0.119-10.114-14.831-14.01-14.095-11.605-7.745-5.723-5.567-6.843-6.475-6.172-6.134-5.142-4.465-4.77-4.337-3.792-1.53-1.834-0.77-1.088-0.77-0.77-0.412-0.412-0.412-0.412-0.247-0.247-0.247-0.247
Operating Income Ratio 0.038-3.359-5.807-4.606-7.451-4.279-4.992-3.868-6.381-4.838-6.212-6.352-4.872-5.797-4.2634.481-4.00812.968-3.4-218.930-4.860000000000
Total Other Income Expenses Net -13.9160.414-1.9820.565-1.433-1.978-1.139-1.019-0.024-1.236-1.032-0.079-0.045-0.04-0.130.030.002-0.017-0.037-0.0770-0.140000000000
Income Before Tax -13.797-9.701-14.178-13.444-13.648-10.854-7.288-5.233-5.592-8.079-6.474-6.212-6.138-5.136-4.55-4.781-4.293-3.809-1.526-1.868-0.77-1.213-0.77-0.77-0.412-0.412-0.412-0.412-0.247-0.247-0.247-0.247
Income Before Tax Ratio -4.401-3.222-5.551-4.42-7.214-4.002-4.697-3.537-6.409-5.712-6.211-6.393-4.876-5.791-4.3444.491-3.96813.026-3.393-223.0490-5.4170000000000
Income Tax Expense 0.0980.075-1.89-2.5-1.384-1.96-1.045-0.974-0.873-1.447-1.00900001.66201.0650-0.266000000000000
Net Income -13.895-9.776-12.288-10.945-12.264-8.894-6.243-4.259-4.719-6.632-5.465-6.212-6.138-5.136-4.55-3.119-4.293-2.744-1.526-1.868-0.77-1.213-0.77-0.77-0.412-0.412-0.412-0.412-0.247-0.247-0.247-0.247
Net Income Ratio -4.432-3.246-4.811-3.598-6.483-3.279-4.024-2.879-5.409-4.689-5.242-6.393-4.876-5.791-4.3442.93-3.9689.385-3.393-223.0490-5.4170000000000
EPS -0.053-0.057-0.15-0.14-0.15-0.11-0.078-0.059-0.089-0.25-0.4-0.48-0.62-0.69-0.66-0.43-0.68-0.79-0.3-0.84-0.24-1.02-0.24-0.24-0.13-0.13-0.13-0.13-0.076-0.076-0.076-0.076
EPS Diluted -0.053-0.052-0.15-0.14-0.15-0.11-0.078-0.059-0.089-0.25-0.4-0.48-0.62-0.69-0.66-0.43-0.68-0.79-0.3-0.84-0.24-1.02-0.24-0.24-0.13-0.13-0.13-0.13-0.076-0.076-0.076-0.076
EBITDA -13.577-10.32-13.633-12.931-13.186-10.446-6.994-4.943-5.314-6.714-6.188-5.914-6.007-4.988-4.301-4.817-4.162-3.72-1.474-1.787-0.753-1.065-0.753-0.753-0.406-0.406-0.406-0.406-0.246-0.246-0.246-0.246
EBITDA Ratio -4.331-3.427-5.62-4.476-7.251-4.149-4.887-3.72-6.155-4.771-6.005-6.087-4.772-5.624-4.1064.524-3.84612.721-3.277-213.3110-4.7590000000000